Renalytix (RNLXY)
OTHER OTC:RNLXY
Holding RNLXY?
Track your performance easily

Renalytix (RNLXY) Income Statement

233 Followers

Renalytix Income Statement

Last quarter (Q ), Renalytix's total revenue was $586.00K, a decrease of -39.53% from the same quarter last year. In Q, Renalytix's net income was $-7.07M. See Renalytix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 3.02M$ 2.29M$ 3.40M$ 2.97M$ 1.49M-
Cost of Revenue
$ 2.34M$ 2.13M$ 2.68M$ 2.10M$ 804.00K-
Gross Profit
$ 708.00K$ 156.00K$ 720.00K$ 874.00K$ 687.00K-
Operating Expense
$ 30.74M$ 29.76M$ 42.94M$ 54.17M$ -32.55M$ 10.31M
Operating Income
$ -30.06M$ -29.61M$ -42.22M$ -53.30M$ -25.43M$ -10.31M
Net Non Operating Interest Income Expense
---$ 40.00K--
Other Income Expense
$ 463.00K$ 451.00K$ -647.00K$ -2.16M$ 1.13M$ -226.00K
Pretax Income
$ -33.74M$ -33.45M$ -45.60M$ -41.44M$ -35.34M$ -9.84M
Tax Provision
$ 4.00K$ 4.00K$ 2.00K$ 25.00K$ -4.78M-
Earnings From Equity Interest Net Of Tax
--$ -9.00K$ -9.00K$ -2.11M$ -63.00K
Net Income Common Stockholders
$ -34.39M$ -33.46M$ -45.61M$ -41.44M$ -31.01M$ -9.84M
Basic EPS
$ -0.25-$ -0.55---
Diluted EPS
$ -0.25-$ -0.55---
Basic Average Shares
$ 194.92M-$ 82.21M---
Diluted Average Shares
$ 194.92M-$ 82.21M---
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 33.11M$ 31.90M$ 45.62M$ 56.27M$ -33.41M$ 10.31M
Net Income From Continuing And Discontinued Operation
$ -34.39M$ -33.46M$ -45.61M$ -41.44M$ -31.01M$ -9.84M
Normalized Income
$ -20.87M$ -25.63M----
Interest Expense
------
EBIT
$ -26.03M$ -33.45M$ -45.60M$ -53.18M$ -35.78M$ -9.84M
EBITDA
$ -25.84M$ -33.09M$ -45.10M$ -52.69M$ -33.69M$ -9.77M
Currency in USD

Renalytix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis